Efficacité osseuse du raloxifène : au-delà des chiffresLEGRAND, Erick.Revue du rhumatisme (Ed. française). 2004, Vol 71, pp 6-10, issn 1169-8330, 5 p., HS1Article

Le raloxifène : un modulateur sélectif du récepteur aux oestrogènes = Raloxifen : a selective estrogen receptor moulatorVAN DEN BRULE, F. A; KALBUS, M.-F; GASPARD, U. J et al.Journal de gynécologie obstétrique et biologie de la reproduction. 1999, Vol 28, Num 8, pp 788-799, issn 0368-2315Article

Bone cell-independent benefits of raloxifene on the skeleton: A novel mechanism for improving bone material propertiesGALLANT, Maxime A; BROWN, Drew M; HAMMOND, Max et al.Bone (New York, NY). 2014, Vol 61, pp 191-200, issn 8756-3282, 10 p.Article

Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trialCHI CHIU MOK; KING YEE YING; CHI HUNG TO et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 5, pp 778-784, issn 0003-4967, 7 p.Article

Safety and adverse effects associated with raloxifene: Multiple Outcomes of Raloxifene EvaluationGRADY, Deborah; ETTINGER, Bruce; MOSCARELLI, Elena et al.Obstetrics and gynecology (New York. 1953). 2004, Vol 104, Num 4, pp 837-844, issn 0029-7844, 8 p.Article

Environmental fate and chemistry of raloxifene hydrochlorideTEETER, Jerold Scott; MEYERHOFF, Roger D.Environmental toxicology and chemistry. 2002, Vol 21, Num 4, pp 729-736, issn 0730-7268Article

Place des serm (selective estrogen receptor modulators) dans la substitution hormonale postménopausique = Place of serms (selective estrogen receptor modulators) for hormone replacement therapy in postmenopausal womenWIRTHNER, D; DE GRANDI, P.Médecine et hygiène. 2000, Vol 58, Num 2312, pp 1677-1681, issn 0025-6749, 4 p.Article

Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trialsCOHEN, F. J; YILI LU.Maturitas (Amsterdam). 2000, Vol 34, Num 1, pp 65-73, issn 0378-5122Article

Les nouvelles molécules estrogéniques = New estrogen moleculesDEGRELLE, H.Reproduction humaine et hormones. 1999, Vol 12, Num 4, pp 327-332, issn 0994-3919Conference Paper

Les modulateurs spécifiques des récepteurs oestrogéniques (SERMs) : Nouvelles thérapeutiques en gynécologie = Specific estrogen receptor modulators (SERMs) : New therapeutics in gynecologyTREMOLLIERES, Florence; LOPES, Patrice.La Presse médicale (1983). 2002, Vol 31, Num 28, pp 1323-1328, issn 0755-4982, 6 p.Article

Role of nociceptor estrogen receptor GPR30 in a rat model of endometriosis painALVAREZ, Pedro; BOGEN, Oliver; LEVINE, Jon D et al.Pain (Amsterdam). 2014, Vol 155, Num 12, pp 2680-2686, issn 0304-3959, 7 p.Article

Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronateKHEDR, Naglaa F; EL-ASHMAWY, Nahla E; EL-BAHRAWY, Hoda A et al.Fundamental & clinical pharmacology. 2013, Vol 27, Num 5, pp 526-534, issn 0767-3981, 9 p.Article

Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized ratsTAKEDA, Satoshi; SAKAI, Sadaoki; SHIRAISHI, Ayako et al.Bone (New York, NY). 2013, Vol 53, Num 1, pp 167-173, issn 8756-3282, 7 p.Article

Effects of Estrogen on Vascular Inflammation A Matter of TimingNOVELLA, Susana; HERAS, Magda; HERMENEGILDO, Carlos et al.Arteriosclerosis, thrombosis, and vascular biology. 2012, Vol 32, Num 8, pp 2035-2042, issn 1079-5642, 8 p.Article

Genistein aglycone, a soy-derived isoflavone, improves skin changes induced by ovariectomy in ratsPOLITO, Francesca; MARINI, Herbert; BITTO, Alessandra et al.British journal of pharmacology. 2012, Vol 165, Num 4, pp 994-1005, issn 0007-1188, 12 p.Article

Ce que les patientes doivent savoir sur le risque osseux et sa prévention = What patients need to know about the risk of bone fracture and its preventionTREMOLLIERES, F.Journal de gynécologie obstétrique et biologie de la reproduction. 2012, Vol 41, Num 7, issn 0368-2315, F20-F27, SUPArticle

Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritisGINER, Mercè; RIOS, Ma José; MONTOYA, Ma José et al.European journal of pharmacology. 2011, Vol 650, Num 2-3, pp 682-687, issn 0014-2999, 6 p.Article

Computational estimation of rainbow trout estrogen receptor binding affinities for environmental estrogensSHYU, Conrad; CAVILEER, Timothy D; NAGLER, James J et al.Toxicology and applied pharmacology. 2011, Vol 250, Num 3, pp 322-326, issn 0041-008X, 5 p.Article

Differential Maintenance of Cortical and Cancellous Bone Strength Following Discontinuation of Bone-Active AgentsSHAHNAZARI, Mohammad; WEI YAO; WANG, Bob et al.Journal of bone and mineral research (Print). 2011, Vol 26, Num 3, pp 569-581, issn 0884-0431, 13 p.Article

Endocrine Therapy of Breast CancerLUMACHI, F; LUISETTO, G; BASSO, S. M. M et al.Current medicinal chemistry. 2011, Vol 18, Num 4, pp 513-522, issn 0929-8673, 10 p.Article

Prevalent vertebral fractures predict subsequent radiographic vertebral fractures in postmenopausal Korean women receiving antiresorptive agentKIM, S. H; CHOI, H. S; RHEE, Y et al.Osteoporosis international. 2011, Vol 22, Num 3, pp 781-787, issn 0937-941X, 7 p.Article

Raloxifene Reduces Blood Pressure in Hypertensive Animals after Ovarian Hormone DeprivationNUNES MORAES, Adriana; ALVES GOUVEA, Sonia; LUIZ SILVA GONCALVES, Washington et al.Basic & clinical pharmacology & toxicology (Print). 2011, Vol 109, Num 5, pp 334-338, issn 1742-7835, 5 p.Article

Structure-Based Approach for the Discovery of Novel Selective Estrogen Receptor ModulatorsROSANO, C; STEC-MARTYNA, E; LAPPANO, R et al.Current medicinal chemistry. 2011, Vol 18, Num 8, pp 1188-1194, issn 0929-8673, 7 p.Article

Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptakeTODOROVA, Valentina K; KAUFMANN, Yihong; SHAOKE LUO et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 2, pp 285-291, issn 0344-5704, 7 p.Article

The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer riskWILLIAMS-BROWN, Marian Y; SALIH, Sana M; XIA XU et al.Journal of steroid biochemistry and molecular biology. 2011, Vol 126, Num 3-5, pp 78-86, issn 0960-0760, 9 p.Article